Fulcrum Therapeutics, Inc. revenue breakdown overview

Fulcrum Therapeutics, Inc. revenue for the last year amounted to 2.81 M USD, the most of which — 2.81 M USD — came from its highest performing source at the moment, Biopharmaceutical, the year earlier bringing 6.34 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Fulcrum Therapeutics, Inc. 2.81 M USD, and the year before that — 6.34 M USD.